Well before Covid-19 came on the scene, telehealth had earned its stripes as a cost-effective care delivery and population health platform.  Despite numerous benefits, telehealth’s potential was marginalized by the lobbying efforts of hospitals, medical associations, and specialists seeking to defend their turf and the lucrative nature of current fee-for-service payment models.  However, Covid-19 has prompted an unprecedented loosening of regulatory and reimbursement restrictions for telehealth-provided services.  With these moves, the telehealth genie is out of the bottle and promises to have an indelible, long-term impact on healthcare business models, health outcomes, and consumer expectations about healthcare convenience and access.

Read More

Thank you for your interest in our content. Registering allows you to access a wide range of informative articles, briefs, and whitepapers throughout the site.

Privacy is important. We do not share registrant information with anyone outside of Numerof & Associates. For details, please see our Privacy Policy. Subscribers to our mailings can unsubscribe instantly at any time.